Association of Systemic Inflammatory Indices with Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
{{output}}
Background/aims: The newly proposed metabolic dysfunction-associated steatotic liver disease (MASLD) framework reflects the evolving understanding of fatty liver disease, highlighting the importance of exploring novel risk factor... ...
